References
- Link M. P., Goorin Am, Horowitz M., et al. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop 1991; 270: 8–14
- Bruland ØS, Pihl A. Immunoscintigraphy and radioimmuno-therapy. Useful approaches in the management of osteogenic sarcoma?. Frontiers of osteosarcoma research, J. Novak. Hogrefe & Huber (ISBN 0-88937-113-x). 1993; 149–59
- Kleinerman E. S., Maeda M., Jaffe N. Liposome-encapsulated muramyl tripeptide: a new biologic response modifier for the treatment of osteosarcoma. Cancer Treat Res 1993; 62: 101–7
- Bruland ØS, Fodstad Ø, Funderud S., Pihl A. New monoclonal antibodies specific for human sarcomas. Int J Cancer 1986; 38: 27–31
- Bruland ØS, Fodstad Ø, Stenwig A. E., Pihl A. Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen. Cancer Res 1988; 48: 5302–9
- Haines D. M., Bruland ØS. Immunohistochemical detection of osteosarcoma-associated antigen in canine osteosarcoma. Anticancer Res 1989; 9: 903–7
- Bruland ØS, Fodstad Ø, Skretting A., Pihl A. Selective localisation of two radiolabeled antisarcoma monoclonal antibodies in human osteosarcoma xenografts. Br J Cancer 1987; 56: 21–5
- Fjeld J. G., Bruland ØS, Benestad H. B., Schjerven L., Stigbrand T., Nustad K. Radio-immunotargeting in immunocompetent animals using intraperitoneal diffusion chambers containing human tumor cells. Br J Cancer 1990; 62: 573–8
- Haines D. M., Bruland ØS, Matte G., Wilkinson A. A., Meric S. M., Fowler J. D. Immunoscintigraphic detection of primary and metastatic spontaneous canine osteosarcoma with F(ab')2 fragments of osteosarcoma-associated monoclonal antibody TP-1. Anticancer Res 1992; 12: 2151–7
- Page R. L., Garg P. K., Garg S., Archer G. E., Bruland ØS, Zalut-Sky MR. PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment. J Nucl Med 1994; 35: 1506–13
- Bruland ØS, Fodstad Ø, Aas M., et al. Immunoscintigraphy of bone sarcomas-results in 5 patients. Eur J Cancer 1994; 30A: 1484–9
- Colcher D., Bird R., Roselli M., et al. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J Natl Cancer Inst 1990; 82: 1191–7
- Adams G. P., McCartney J. E., Tai M. S., et al. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv. Cancer Res 1993; 53: 4026–34
- Yokota T., Milenic D. E., Whitlow M., Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 1992; 52: 3402–8
- Pietersz G. A., Rowland A., Smyth M. J., McKenzie I. F. Chemoimmunoconjugates for the treatment of cancer. Adv Immunol 1994; 56: 301–87
- Olafsen T., Bruland ØS, Zalutsky M. R., Sandlie I. Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: Location of lysine residues and implications for radiolabeling. Nucl Med Biol 1995; 22: 765–71
- Orlandi R., Güssow D. H., Jones P. T., Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 3833–7
- Messing J. New M13 vectors for cloning. Methods Enzymol 1983; 101: 20–78
- Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463–7
- Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucl Acids Res 1984; 12: 387–95
- Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S., Foeller C. Sequences of proteins of immunological interest. 5th ed. Publich Health Service, NIH, Washington D. C. 1991
- Chothia C., Lesk A. M. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987; 196: 901–17
- Chothia C., Lesk A. M., Tramontano A., et al. Conformations of immunoglobulin hypervariable regions. Nature 1989; 342: 877–83
- Smith-Gill S. J., Mainhart C., Lavoie T. B., Feldman R. J., Drohan W., Brooks B. R. A three-dimensional model of an antilysozyme antibody. J Mol Biol 1987; 194: 713–24
- Padlan E. A., Silverton E. W., Sheriff S., Cohen G. H., Smith-Gill S. J., Davies D. R. Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci USA 1989; 86: 5938–42
- Abergel C., Tipper J. P., Padlan E. A. Structural significance of sequence variability in antibody complementarity-determining regions. Res Immunol 1994; 145: 49–53
- Padlan E. A. Anatomy of the antibody molecule. Mol Immunol 1994; 31: 169–217
- Zalutsky MR. Radiohalogenation of antibodies: chemical aspects. Radiolabeled monoclonal antibodies for imaging and therapy, S. C. Srivastava. Plenum Press, New York 1988; 195–212
- Seon B. K., Roholt O. A., Pressman D. Reactivity of tyrosine residues in the constant portion of type K Bence Jones protein. Biochim Biophys Acta 1970; 200: 81–8
- Dube S. K., Roholt O. A., Pressman D. Relative reactivity to iodination of tyrosine residues in alpha-chymtrypsin. J Biol Chem 1966; 241: 4665–9
- Schulz G. E., Schirmer R. H. Principles of protein structure. Springer-Verlag, New York 1978
- Wolff J., Covelli I. Iodination of the normal and buried tyrosyl residues of lysozyme II. Spectrophotometry analysis. Biochemistry 1996; 5: 867–71